Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
Abstract Background Lymphopenia has been associated with inferior cancer outcomes, but there is limited data in breast cancer. We describe the effects of neoadjuvant chemotherapy on circulating immune cells and its association with pathological complete response (pCR) rates in triple negative breast...
Saved in:
| Main Authors: | Sarah Talamantes, Eric Xie, Ricardo L. B. Costa, Melissa Chen, Alfred Rademaker, Cesar A. Santa‐Maria |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-10-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.3358 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of HER2-low expression on the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer
by: Lin-Yu Xia, et al.
Published: (2025-06-01) -
Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancer
by: Monika Drobniene, et al.
Published: (2025-04-01) -
Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
by: Ruiliang Chen, et al.
Published: (2024-12-01) -
Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry
by: Tomoe Taji, et al.
Published: (2025-06-01) -
An ultrasound-based model for predicting the response to neoadjuvant chemotherapy in early stage triple negative breast cancer patients
by: Yuyang Tong, et al.
Published: (2025-07-01)